kaempferol

Overview

Kaempferol is a naturally occurring flavonol belonging to the 2-phenylchromane flavonoid class, widely distributed across fruits, vegetables, and medicinal plants. It is found in dietary sources such as kale, broccoli, tea, and a range of botanical extracts, and has been isolated from species including Carissa macrocarpa, Moringa oleifera, and Anoectochilus roxburghii. Structurally, kaempferol frequently occurs in plant tissues as flavonoid glycosides, where it is conjugated with various sugar moieties, and can be released as a free aglycone through enzymatic or fermentative processing. Its pharmacological profile is broad, encompassing anti-inflammatory, antioxidant, antifibrotic, anticancer, and antimicrobial activities, making it a subject of sustained interest across multiple therapeutic domains.

The mechanism of action of kaempferol is multifactorial. It modulates the expression of proinflammatory cytokines including Interleukin 1 beta and IL18, suppresses oxidative stress through upregulation of enzymes such as superoxide dismutase, and attenuates extracellular matrix degradation in degenerative and fibrotic conditions. Kaempferol has also been shown to interact with key signaling nodes including TP53, Prostaglandin-endoperoxide synthase 2, TLR4/P2X7-NLRP3 signaling pathway components, and caspase cascades. Despite this promising pharmacological breadth, its clinical translation has historically been constrained by poor aqueous solubility and limited bioavailability, driving active research into advanced delivery systems.

Focus of Latest Publications

Recent publications reveal kaempferol as a multitarget bioactive compound with broad therapeutic applications across inflammatory, metabolic, and neurodegenerative diseases. Research has investigated its efficacy in rheumatoid arthritis, hepatocellular carcinoma, intervertebral disc degeneration, systemic sclerosis, amyotrophic lateral sclerosis, psoriasis, and oral wound healing. Mechanistically, kaempferol modulates several interconnected signaling pathways implicated in disease pathogenesis, including MAPK, AKT-mTOR, NLRP3 inflammasome, STING/NF-κB, and oxidative stress responses, positioning it as a promiscuous modulator of inflammatory and metabolic dysfunction.

In inflammatory and autoimmune disorders, kaempferol exerts protective effects through multipronged mechanisms. In rheumatoid arthritis, kaempferol suppressed pro-inflammatory cytokines (IL-1β, TNF-α, IL-17A, IL-18) and cartilage-degrading enzymes (MMP-13), with effects comparable to methotrexate in nanoparticle formulations. When incorporated into traditional Chinese medicine formulas, kaempferol inhibited NLRP3/Caspase-1/GSDMD-mediated pyroptosis in rheumatoid arthritis cells and animal models, while simultaneously targeting the STING/NF-κB pathway to suppress skin inflammation and angiogenesis in psoriasis. For intervertebral disc degeneration, kaempferol downregulated three core pathogenic genes—STAT1, CASP1, and NOX4—while restoring extracellular matrix components and suppressing matrix-degrading enzymes in nucleus pulposus cells.

Kaempferol's therapeutic potential extends to metabolic and neurodegenerative disease states through distinct molecular mechanisms. In hepatocellular carcinoma cells, kaempferol inhibited glycolysis and proliferation by suppressing the AKT-mTOR pathway and downregulating glycolytic rate-limiting enzymes (PKM2, HK2), while reducing glucose uptake and lactate production. In amyotrophic lateral sclerosis models, kaempferol protected motor neurons from ferroptosis by upregulating antioxidant defense proteins (GPX4, SLC7A11) while downregulating pro-ferroptotic factors (ACSL4), preserving neuronal and mitochondrial integrity. For systemic sclerosis-related skin fibrosis, kaempferol suppressed myofibroblast activation and downregulated TGF-β/Smad signaling pathways, and studies identified kaempferol as a participant in glucose and lipid metabolism regulation.

A major research focus has been overcoming kaempferol's inherently poor solubility and bioavailability through advanced delivery systems. Multiple studies employed nanoparticle formulations—including solid lipid nanoparticles, liposomes, liposome-exosome composites, zein-coated liposomes, and injectable hydrogels—which significantly enhanced drug stability, cellular uptake, and biological activity. These delivery innovations improved kaempferol's therapeutic efficacy in multiple disease models, with nanoparticle-encapsulated formulations demonstrating superior antioxidant capacity, reduced inflammatory marker expression, and enhanced wound healing compared to free kaempferol, establishing nanotherapeutic strategies as a promising approach to unlock kaempferol's therapeutic potential.